International Conf on Alzheimer Disease and Related Disorders in the Middle East
Principal Investigator: Changiz Geula
Abstract: DESCRIPTION (provided by applicant): Alzheimer's disease is a major health problem and the leading cause of dementia in the Americas and Europe. There has been little work done on dementia in the Middle East. This is an important issue because of the progressive aging of the populations of the world, including the Middle East. For example, the size of the population of Egyptians 60 years and older is expected to increase by 316% from 2000 to 2030. Also, public awareness of dementia in the Middle East is low, and in many cases demented patients do not receive medical attention. The goal of this proposal is to obtain support for the Sixth International Conference on Alzheimer's Disease and Related Disorders in the Middle East. The objectives of this conference are to focus attention on neurodegenerative disorders of the aged, particularly Alzheimer's Disease, in the Middle East, to raise scientific, medical and social awareness of these disorders, and to enhance communication between Arab and Jewish medical and scientific personnel as well as communication between Middle Eastern workers and their counterparts in other countries, particularly the USA. It is anticipated that the meetin will lead to increased studies of dementia in the Middle East, a region with unique features valuable for research, including a high rate of consanguinity and smoking, relatively homogenous populations, and high fat diet. The primary organizers are from Middle Eastern background and are thoroughly familiar with the cultural traditions of the region, and along with the past organizer of these conferences, have built continuing collaborative relationships with works in the Middle East. A target audience of clinicians, scientists, nurses, social workers, government representatives and other agencies, pharmaceutical and other biotechnology companies will attend the meeting to be held in Istanbul, Turkey, March 23-24, 2013. Attendees will be from the majority of Middle Eastern countries including Bahrain, Egypt, Iran, Israel, Jordan, Lebanon, Palestinian Authority, Qatar, Saudi Arabia, Syria, Tunisia, Turkey, United Arab Emirates and the West Bank and will include will include workers from Europe, North America and other parts of the world. Topics to be covered include clinical and basic science aspects of dementia, diagnoses, history, management, treatment, and ethics, with consideration of the unique cultural traditions of Arab and Jewish populations. The organizers have successfully convened five editions of this conference in the past, and based on past experience expect an even more successful sixth conference.
Funding Period: 2013-04-01 - 2014-03-31
more information: NIH RePORT
- Emory Alzheimer's Disease CenterAllan I Levey; Fiscal Year: 2013..abstract_text> ..
- INNATE AND ADAPTIVE IMMUNE RESPONSES IN TH2-HIGH ASTHMAJohn V Fahy; Fiscal Year: 2013..Including studies in human biospecimens in a PPG that promises to advance understanding of airway TH2 inflammation in ways that are highly relevant to patients with asthma. ..
- Center for Novel Therapeutics for HIV-Associated Cognitive DisordersJustin C McArthur; Fiscal Year: 2013..5. To identify and validate surrogate biomarkers based on proteomics and lipomics. ..
- Alzheimer's Disease Core CenterJohn Q Trojanowski; Fiscal Year: 2013..abstract_text> ..
- SCHS, mitochondria, healthy aging and longevityGino A Cortopassi; Fiscal Year: 2013..abstract_text> ..
- Massachusetts Alzheimer's Disease Research CenterBradley T Hyman; Fiscal Year: 2013..Going forward, the MADRC will continue to expand its clinical and neuropathological resources, its innovative training and scientific programs directed toward AD research. ..
- Alzheimer's Disease Research CenterThomas J Montine; Fiscal Year: 2013..Montine;Project 2: Therapeutic Effects of Intra-Nasal Insulin Detemir, Dr. Suzanne Craft;Project 3: Modulation of A peptide accumulation and neuron damage in vivo with adult bone marrow transplants, Dr. C. Dirk Keene. ..
- Novel molecular and cellular approaches for alcoholism medication developmentRobert A Harris; Fiscal Year: 2013..The PPG has both internal and external advisory board members, providing expert guidance from scientists with a wide range of expertise in drug development and therapeutics. ..
- NBER CENTER FOR AGING AND HEALTH RESEARCHDAVID A WISE; Fiscal Year: 2013..Understanding the complexities of this situation and the relationships between demographics, policy, behavior, economics, and health is the substantive aim of the Center. ..
- CENTER ON DEMOGRAPHY AND ECONOMICS OF AGING (COA)Linda J Waite; Fiscal Year: 2013....
- Rush Alzheimer's Disease Core CenterDavid Alan Bennett; Fiscal Year: 2013..The Data Management and Biostatistics Core, begun in 1995, will continue to support all other Cores with PC- and web-based services and processes, and provide statistical support to users of Rush ADCC resources. ..